Life Sciences

Powering real world
evidence (RWE)

Huma is enabling biopharmaceutical and medical device companies to extract deeper insights into the use and performance of treatments in real world settings, through the collection and analysis of real world data.

The current situation

The increasing value
of RWE
across the
product life cycle

RWE is increasingly being used by biopharmaceutical and medical device companies to aid clinical trial design, regulatory approvals, surveillance, comparative effectiveness, and value in the real world.

Our offering

Supporting
stakeholders
across
the life science sector

Illustration of clinicians and patients using the platform. Illustration of clinicians and patients using the platform.

Huma's mobile platform technology supports the collection of patient-generated data as part of real world studies, such as registries and post-approval surveillance studies.

By partnering with leading RWE data generators, combining their real world data sources with digital patient-generated data, and through the application of AI technologies, we are enabling life sciences companies to extract data-driven insights from real world sources.

As part of these programs, Huma's portfolio of digital measures, biomarkers and technology for clinical trials are providing more objective, continuous insights into disease signs, symptoms, and patient behaviours and outcomes, for proactive, preventative health.

Our offering

How real world
evidence
can help you

participants and carers
Participants/Carer

Support physicians to make well-informed, data-driven improvements to the standard of care.

Improve insights into service provision and treatment patterns.

Improve the efficiency of care with improved decision making and care pathways.

pharma
Pharma

Inform disease understanding and improve clinical trial designs.

Enable efficient expansion of drug labels into new indications.

Support post-marketing commitments to monitor drug safety.

Generate evidence of real world efficacy supporting the demonstration of value and pricing/reimbursement decisions with payers.

payers
Payers

Enable more accurate assessments of clinical and economic advantages for a given therapy to support reimbursement.

Improve affordability of therapies and support movement to value-based pricing.

Increase patient access to therapies.

Ensure the right patients receive the right treatments.

regulators
Regulators

Provide essential insights to verify the findings of randomised clinical trials (RCT).

Support expansion of drug labels into new indications.

Support post-marketing commitments to monitor the safety of marketed products.

Participants/Carer

Support physicians to make well-informed, data-driven improvements to the standard of care.

Improve insights into service provision and treatment patterns.

Improve the efficiency of care with improved decision making and care pathways.

Pharma

Inform disease understanding and improve clinical trial designs.

Enable efficient expansion of drug labels into new indications.

Support post-marketing commitments to monitor drug safety.

Generate evidence of real world efficacy supporting the demonstration of value and pricing/reimbursement decisions with payers.

Payers

Enable more accurate assessments of clinical and economic advantages for a given therapy to support reimbursement.

Improve affordability of therapies and support movement to value-based pricing.

Increase patient access to therapies.

Ensure the right patients receive the right treatments.

Regulators

Provide essential insights to verify the findings of randomised clinical trials (RCT).

Support expansion of drug labels into new indications.

Support post-marketing commitments to monitor the safety of marketed products.

  • Participants/Carer
  • Trusted Partner
  • Payers
  • Regulators

Supporting real
world
research
studies

Huma’s patient app accurately and securely captures high-frequency, real-life, patient-generated data from sensors, devices, eDiaries, ePROs, and ePerfOs.

Huma’s dashboard provides a continuous stream and early access to meaningful data.

Our platform is configurable from a diverse library of over 100 data capture modules to create tailored deployments for different therapeutic areas.

Devices showing patient-generated data.

Why Huma?

Benefits of RWE in
supporting life sciences

Core benefits

trusted partner
Trusted Partner

Medical device grade platform built under a Quality Management System compliant with global security, privacy and regulatory requirements

experienced
Experienced

Deployments with top 10 pharma companies, national governments, major healthcare providers and leading research institutions

globally deployable
Globally Deployable

Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language

integration
Integration

Our RWE platform and captured data can be efficiently transferred and integrated with other clinical data sources as well as other platforms (e.g. EDC in clinical trials or EMR in real world settings)

device agnostic
Flexible

Our platform can be configured from a diverse library of 100+ data capture modules to create tailored deployments for different therapeutic areas

Trusted Partner

Medical device grade platform built under a Quality Management System compliant with global security, privacy and regulatory requirements.

Experienced

Deployments with top 10 pharma companies, national governments, major healthcare providers and leading research institutions.

Globally Deployable

Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language.

Integration

Our RWE platform and captured data can be efficiently transferred and integrated with other clinical data sources as well as other platforms (e.g. EDC in clinical trials or EMR in real world settings).

Flexible

Our platform can be configured from a diverse library of 100+ data capture modules to create tailored deployments for different therapeutic areas.

  • Trusted Partner
  • Experienced
  • Globally Deployable
  • Integration
  • Flexible
Mobile app showing patient questionnaire, to dos and symptoms tracker. Mobile app showing patient questionnaire, to dos and symptoms tracker.

Supporting patients
undergoing knee/hip
replacement surgeries

Huma and Smith & Nephew partnered on a digital solution that remotely supports patients before and after knee/hip replacement surgery. The solution allows surgeons to assess pre-op readiness and collect valuable real-world data on patient outcomes, enabling S&N to have real-time visibility on the efficacy of their devices.

The dataset will form a central part of Smith & Nephew’s real-world evidence strategy, allowing an improved understanding of post-surgery outcomes.

This field is required

This field is required

This field is required

This field is required

This field is required

Huma is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow Huma to store and process the personal information submitted above to provide you the content requested.

thumbs up
One of our team members will be in touch with you shortly.
There was an error submitting your form. Please refresh and try again.